MBMarion Biermans

Marion Biermans

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marion Biermans has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Estimating incidence and prevalence rates of chronic diseases using disease modeling

    by Hendrike C. Boshuizen, Marinus J. J. C. Poos, Marjan van Den Akker, Kees van Boven, Joke C. Korevaar, Margot W. M. de Waal, Marion C. J. Biermans, Nancy Hoeymans

    Morbidity estimates between different GP registration networks show large, unexplained variations. This research explores the potential of modeling differences between networks in distinguishing new (incident) cases from existing (prevalent) cases in obtaining more reliable estimates. Data from five Dutch GP registration networks and data on four chronic diseases (chronic obstructive pulmonary disease [COPD], diabetes, heart failure, and osteoarthritis of the knee) were used. A joint model (DisMod model) was fitted using all information on morbidity (incidence and prevalence) and mortality in each network, including a factor for misclassification of prevalent cases as incident cases. The observed estimates vary considerably between networks. Using disease modeling including a misclassification term improved the consistency between prevalence and incidence rates, but did not systematically decrease the variation between networks. Osteoarthritis of the knee showed large modeled misclassifications, especially in episode of care-based registries. Registries that code episodes of care rather than disease generally provide lower estimates of the prevalence of chronic diseases requiring low levels of health care such as osteoarthritis. For other diseases, modeling misclassification rates does not systematically decrease the variation between registration networks. Using disease modeling provides insight in the reliability of estimates.


  • Open Access

    Prevalence and incidence density rates of chronic comorbidity in type 2 diabetes patients: an exploratory cohort study

    by Hilde Luijks, Tjard Schermer, Hans Bor, Chris van Weel, Toine Lagro-Janssen, Marion Biermans, Wim de Grauw

    Evidence-based diabetes guidelines generally neglect comorbidity, which may interfere with diabetes management. The prevalence of comorbidity described in patients with type 2 diabetes (T2D) shows a wide range depending on the population selected and the comorbid diseases studied. This exploratory study aimed to establish comorbidity rates in an unselected primary-care population of patients with T2D.


  • Open Access

    The influence of population characteristics on variation in general practice based morbidity estimations

    by C van Den Dungen, N Hoeymans, Hc Boshuizen, M van Den Akker, Mcj Biermans, K van Boven, Hj Brouwer, Ra Verheij, Mwm de Waal, Fg Schellevis, et al.

    General practice based registration networks (GPRNs) provide information on morbidity rates in the population. Morbidity rate estimates from different GPRNs, however, reveal considerable, unexplained differences. We studied the range and variation in morbidity estimates, as well as the extent to which the differences in morbidity rates between general practices and networks change if socio-demographic characteristics of the listed patient populations are taken into account.


  • Decreasing incidence of adenotonsillar problems in Dutch general practice: real or artefact?

    by Marion Cj Biermans, Ellen Hm Theuns-Lamers, Peter Spreeuwenberg, Robert A Verheij, Johannes C van der Wouden, Pieter F de Vries Robbé, Gerhard A Zielhuis

    The incidence of hypertrophy and recurrent infections of the tonsils/adenoids appears to be decreasing in the Netherlands. It is uncertain whether this is a 'real' decrease in the incidence of disease or an 'artefact'. To investigate possible causes of the decreasing incidence of adenotonsillar problems among Dutch children. Observational. A nationally representative general practice database. Incidence rates were calculated over 2002-2005 among children aged 0-14 years. Multilevel Poisson regression analyses were used to examine the following possible causes of changing incidence rates: change in recording (more substitution codes), change in the demand for care (fewer visits to the GP), and change in the supply of care (fewer antibiotic prescriptions and referrals). Indications for a 'real' change in the incidence of disease were examined by calculating incidence rates of other clinical manifestations of microbial pathogens that may cause adenotonsillar problems. The incidence rate decreased significantly (P = 0.017) from 3.0 to 1.3 per 1000 children per year. Correcting for demand for and supply of care led to a smaller decline in yearly incidence, from 2.9 to 1.7 per 1000 children per year (P = 0.105). No clearly similar trend was found in other clinical manifestations of viruses and bacteria that may cause adenotonsillar problems. Part of the declining trend can be explained by a change in the demand for and supply of care, but no apparent causal clue emerged for the residual declining trend in the incidence of disease.